MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$23,363K
US
$401,547K
Non Us
$119,765K
Loss before
provision for income taxes
-$21,427K
Provision for income taxes
$1,936K
Interest income
$12,727K
Product
$521,312K
Other income
(expense), net
$2,371K
Loss from operations
-$22,136K
Total revenue
$521,312K
Interest expense
$14,389K
Total operating
expenses
$543,448K
Selling, general and
administrative
$257,030K
Research and development
$186,178K
Cost of sales
$100,240K
Back
Back
Income Statement
source: myfinsight.com
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)